← Back to Dashboard

THYROCARE THYROCARE — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Unknown
₹ 618.60
-0.87%
1-year price · range ₹347–₹643

Live setups screens THYROCARE is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about THYROCARE

THYROCARE did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.

On the institutional side, MFs are building positions in THYROCARE — the most recent notable was HSBC MUTUAL FUND on the buy side at ₹187 Cr.

Putting it together, the smart-money picture for THYROCARE lacks a clear directional bias.

F&O Positioning EOD derivatives setup

Buildup Class
no futures data
Futures OI
EOD details
Option PCR (OI)
no EOD options
Max Pain Strike
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 624.05
yesterday's EOD close
Index Contribution
not a Nifty 50 constituent
Traded Volume
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 250 sessions of price history

RSI (14)
59.2
neutral momentum
52-Week High
₹ 662.00
-6.6% from high
52-Week Low
₹ 338.15
+82.9% above low
200-DMA
₹ 462.52
+33.7% · above trend
50-DMA
₹ 558.03
+10.8% from 50-DMA
1-Year Return
1M +18.8%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
56.0
price / earnings
P/B
16.8
price / book
ROE
return on equity
Market Cap
₹ 9,846 Cr
total market value
Dividend Yield
2.64%
trailing yield
EPS (TTM)
₹ 11.05
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

Date Side Price Value (Cr) Counterparty
2026-08-13 SELL ₹ 624.00 821.72 DOCON TECHNOLOGIES PRIVATE LIMITED
2026-08-13 SELL ₹ 624.00 821.72 DOCON TECHNOLOGIES PRIVATE LIMITED
2026-08-13 BUY ₹ 624.00 187.18 HSBC MUTUAL FUND MF
2026-08-13 BUY ₹ 624.00 187.18 HSBC MUTUAL FUND MF
2026-08-13 BUY ₹ 624.00 149.76 KOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED Insurance
2026-08-13 BUY ₹ 624.00 149.76 KOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED Insurance
2026-08-13 BUY ₹ 624.00 82.45 DSP MUTUAL FUND MF
2026-08-13 BUY ₹ 624.00 82.45 DSP MUTUAL FUND MF
2026-08-13 SELL ₹ 631.71 63.17 DOCON TECHNOLOGIES PRIVATE LIMITED
2026-08-13 BUY ₹ 624.00 49.98 ICICI PRUDENTIAL MUTUAL FUND MF

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

THYROCARE — frequently asked questions

What is the THYROCARE share price today?

THYROCARE is trading at ₹618.60 (-0.87% vs previous close), per the latest update on this page.

What is the P/E ratio of THYROCARE?

THYROCARE (THYROCARE) has a trailing twelve-month P/E ratio of 56.0.

What is the market cap of THYROCARE?

THYROCARE has a market capitalisation of approximately ₹9,846 crore.

Is THYROCARE near its 52-week high?

THYROCARE is trading -6.6% from its 52-week high of ₹662.00.

What is the RSI of THYROCARE?

The 14-day RSI of THYROCARE is 59.2, which is considered neutral.

Is THYROCARE above its 200-day moving average?

THYROCARE is trading above its 200-DMA of ₹462.52 (+33.7% away).

Are FIIs or big investors buying THYROCARE?

Strota tracks every bulk and block deal in THYROCARE with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.